Development of Triamcinolone Acetonide Nanocrystals for Ocular Administration
暂无分享,去创建一个
R. Faccio | S. Palma | L. Tártara | M. L. Formica | A. Paredes | M. E. Melian | H. G. Awde Alfonso | N. Camacho
[1] B. Karasu,et al. Efficacy of topical dexamethasone eye drops in preventing ocular inflammation and cystoid macular edema following uncomplicated cataract surgery with or without injection of a single dose perioperative subtenon triamcinolone acetonide , 2022, Cutaneous and ocular toxicology.
[2] José Izo Santana da Silva de Jesus,et al. Besifloxacin Nanocrystal: Towards an Innovative Ophthalmic Preparation , 2022, Pharmaceutics.
[3] A. Silva,et al. Customized cationic nanoemulsions loading triamcinolone acetonide for corneal neovascularization secondary to inflammatory processes. , 2022, International journal of pharmaceutics.
[4] R. Donnelly,et al. Nanosuspension-loaded dissolving bilayer microneedles for hydrophobic drug delivery to the posterior segment of the eye. , 2022, Biomaterials advances.
[5] S. Palma,et al. Nanocrystals as a master key to deliver hydrophobic drugs via multiple administration routes. , 2022, Journal of controlled release : official journal of the Controlled Release Society.
[6] M. L. Formica,et al. Manufacturing Techniques for Nanoparticles in Drug Delivery , 2021, Drug Delivery Using Nanomaterials.
[7] A. Yousaf,et al. Drug Delivery Using Nanomaterials , 2021 .
[8] Moiz Ahmed,et al. Safety and Efficacy of Suprachoroidal Injection of Triamcinolone in Treating Macular Edema Secondary to Noninfectious Uveitis , 2021, Cureus.
[9] S. Ismail,et al. Development of Triamcinolone Acetonide-Loaded Microemulsion as a Prospective Ophthalmic Delivery System for Treatment of Uveitis: In Vitro and In Vivo Evaluation , 2021, Pharmaceutics.
[10] Makoto Nakamura,et al. A case of panuveitis and retinal vasculitis associated with pembrolizumab therapy for metastatic lung cancer , 2021, American journal of ophthalmology case reports.
[11] B. Pierscionek,et al. Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives , 2020, Drug Delivery and Translational Research.
[12] R. Faccio,et al. Nanocrystals of Novel Valerolactam-Fenbendazole Hybrid with Improved in vitro Dissolution Performance , 2020, AAPS PharmSciTech.
[13] C. Lanusse,et al. Ricobendazole nanocrystals obtained by media milling and spray drying: pharmacokinetic comparison with the micronized form of the drug. , 2020, International journal of pharmaceutics.
[14] J. Benoit,et al. Triamcinolone acetonide-loaded lipid nanocapsules for ophthalmic applications. , 2020, International journal of pharmaceutics.
[15] Vikram Patel,et al. Application of Mechanistic Ocular Absorption Modeling and Simulation to Understand the Impact of Formulation Properties on Ophthalmic Bioavailability in Rabbits: a Case Study Using Dexamethasone Suspension , 2019, The AAPS Journal.
[16] Haiyan Hu,et al. Drug nanocrystals: Fabrication methods and promising therapeutic applications. , 2019, International journal of pharmaceutics.
[17] E. Duh,et al. Controlled release of corticosteroid with biodegradable nanoparticles for treating experimental autoimmune uveitis , 2019, Journal of controlled release : official journal of the Controlled Release Society.
[18] Y. Qu,et al. A more efficient ocular delivery system of triamcinolone acetonide as eye drop to the posterior segment of the eye , 2019, Drug delivery.
[19] Qin-Mei Wang,et al. Directing the nanoparticle formation by the combination with small molecular assembly and polymeric assembly for topical suppression of ocular inflammation , 2018, International journal of pharmaceutics.
[20] Arturo Santos,et al. Characterization and Pharmacokinetics of Triamcinolone Acetonide-Loaded Liposomes Topical Formulations for Vitreoretinal Drug Delivery. , 2018, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[21] F. Otero-Espinar,et al. Solid-state characterization of triamcinolone acetonide nanosuspensiones by X-ray spectroscopy, ATR Fourier transforms infrared spectroscopy and differential scanning calorimetry analysis , 2017, Data in brief.
[22] F. Otero-Espinar,et al. Improved release of triamcinolone acetonide from medicated soft contact lenses loaded with drug nanosuspensions. , 2017, International journal of pharmaceutics.
[23] S. Lee,et al. Development Considerations for Nanocrystal Drug Products , 2017, The AAPS Journal.
[24] Jouni Hirvonen,et al. Stabilizing Agents for Drug Nanocrystals: Effect on Bioavailability , 2016, Pharmaceutics.
[25] S. Palma,et al. Self-dispersible nanocrystals of albendazole produced by high pressure homogenization and spray-drying , 2016, Drug development and industrial pharmacy.
[26] Yong Woo Lee,et al. Triamcinolone acetonide nanoparticles incorporated in thermoreversible gels for age-related macular degeneration , 2016, Pharmaceutical development and technology.
[27] P. Massin,et al. INTRAVITREAL CORTICOSTEROIDS IN DIABETIC MACULAR EDEMA , 2015, Retina.
[28] F. Boscia,et al. Intravitreal Steroids for the Treatment of Retinal Diseases , 2014, TheScientificWorldJournal.
[29] M. Ghahremani,et al. Polymeric triamcinolone acetonide nanoparticles as a new alternative in the treatment of uveitis: in vitro and in vivo studies. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[30] E. Souto,et al. Release profile and transscleral permeation of triamcinolone acetonide loaded nanostructured lipid carriers (TA-NLC): in vitro and ex vivo studies. , 2012, Nanomedicine : nanotechnology, biology, and medicine.
[31] Lei Gao,et al. Drug nanocrystals: In vivo performances. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[32] R. Müller,et al. Twenty years of drug nanocrystals: where are we, and where do we go? , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[33] O. Kul,et al. A cannabinoid ligand, anandamide, exacerbates endotoxin-induced uveitis in rabbits. , 2011, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[34] Jan Van Humbeeck,et al. Solubility increases associated with crystalline drug nanoparticles: methodologies and significance. , 2010, Molecular pharmaceutics.
[35] V. Chikán,et al. Quantized Ostwald Ripening of Colloidal Nanoparticles , 2010 .
[36] Michael D. Ober,et al. Intravitreal triamcinolone acetonide and intraocular pressure. , 2004, American journal of ophthalmology.
[37] P. Wiedemann,et al. Inhibitory effects of triamcinolone acetonide on bFGF-induced migration and tube formation in choroidal microvascular endothelial cells , 2001, Graefe's Archive for Clinical and Experimental Ophthalmology.
[38] A. Noyes,et al. The rate of solution of solid substances in their own solutions , 1897 .